Session Details

[LS-50]Luncheon Seminar 50 Treatment of EGPA with a Long-term Prognosis and the Role of Mepolizumab

Sat. May 24, 2025 12:15 PM - 1:15 PM JST
Sat. May 24, 2025 3:15 AM - 4:15 AM UTC
第10会場(大阪国際会議場11F 会議室1101-1102)
Chair: Sonoko Misawa(Department of Neurology and Neurological Science, Institute of Science Tokyo, Japan)
Sponsored by: GlaxoSmithKline K.K.

[LS-50-1]Considering Neuropathy in EGPA: Expectations for Mepolizumab in Treating EGPA

Masaru Yokoe (Director of Neurology, Toyonaka Municipal Hospital, Japan)